Home
World Journal of Biological and Pharmaceutical Research
Peer-Reviewed • ISSN: 2799-0338 • Impact Factor 7.8

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

🌟 🧬 World Journal of Biological and Pharmaceutical Research (WJBPR) 🧬 🌟

Low-Cost Journal Publication | CrossRef DOI | Transparent Peer Review Process

International, Open Access, Peer-Reviewed, Multidisciplinary Journal in Biological and Pharmaceutical Sciences, Indexed in Major Databases, DOI Assignment (Crossref)

ISSN: 2799-0338 | Impact Factor: 7.8 | ESTD Year: 2021 | Charges 35 USD

Published paper PDF, E-certificate of publication, Official letter of acceptance, Peer review report, Cover page, Editorial information, and Indexing details.

📄 Submit Paper 👉 Author Guidelines

The expression of Cox-2 and Cyclin D1 with clinicopathological characteristics in oral epithelial dysplasia: A retrospective study

Breadcrumb

  • Home
  • The expression of Cox-2 and Cyclin D1 with clinicopathological characteristics in oral epithelial dysplasia: A retrospective study

Mustafa Mohammed Abdulhussain *

Department of Oral Pathology, College of Dentistry, Mustansiriyah University, Baghdad, Iraq.

Research Article
World Journal of Biological and Pharmaceutical Research, 2023, 05(02), 031–037.
Article DOI: 10.53346/wjbpr.2023.5.2.0071
DOI url: https://doi.org/10.53346/wjbpr.2023.5.2.0071

Received on 24 October 2023; revised on 24 December 2023; accepted on 27 December 2023

Background: Oral mucosal cancers are often preceded by potentially malignant diseases that may exhibit diverse morphological and histological alterations. The expression of COX 2 has been related to tumor vascularization, dissemination, and survival in oral cancer studies. High levels of cyclin D1 expression to precancerous lesions and oral malignancies. This study was designed to evaluate and compare the immunohistochemical expression of the above-mentioned markers.
Materials and Methods: 50 retrospective formalin fixed-paraffin embedded histopathologically confirmed blocks of oral epithelial dysplasia. Immunohistochemical staining was performed using monoclonal antibodies against COX-2 and Cyclin D1. Using a standard camera, photomicrographs of the slides were taken.
Results: No significant difference in the age distribution of the patients studied, as well as age pivoting at the fifth and sixth decades with mean and standard deviation (53.36 2.63). There was no significant difference in gender among the studied patients. Furthermore, there was a highly significant difference in grade distribution.
Conclusions: The COX-2 and Cyclin D1 markers may assist in diagnosing oral epithelial dysplasia based on severity. It's easy to gather image-analytic data on the stained tissue specimens.
 

Epithelial Dysplasia; Malignancy; Cox-2; Cyclin D1; Immunohistochemistry
 

https://wjbpr.zealjournals.com/sites/default/files/fulltext_pdf/WJBPR-2023-0071…

Preview Article PDF

Mustafa Mohammed Abdulhussain. The expression of Cox-2 and Cyclin D1 with clinicopathological characteristics in oral epithelial dysplasia: A retrospective study. World Journal of Biological and Pharmaceutical Research, 2023, 05(02), 031–037. Article DOI: https://doi.org/10.53346/wjbpr.2023.5.2.0071

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Biological and Pharmaceutical Research - All rights reserved

Developed & Designed by VS Infosolution